Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

BlackBio (Group)

Founded in 2009, BlackBio is positioned as a leader in the fields of personalized medicine, medical diagnostics and pharmacogenomics by providing solutions through high-sensitive microsequencing, focusing its developments in the areas of metabolism, oncology, cardiovascular and microbiology. BlackBio, has started its activity in the Spanish market with a medium term objective to become a company with strong international presence and a solid product portfolio. By 2015, BlackBio estimates to reach annual sales of 20 million euros (75% in the international market). *


Period Start 2009-01-01 established
  Today 2B BlackBio S.L.
Products Industry pharmacogenomics/pharmacogenetics
  Industry 2 BIOTECH
Region Region Madrid
  Country Spain (España)
  Street 7 C/ Faraday
Parque Cientifico de Madrid, 2° planta (Cantoblanco)
  City 28049 Madrid
  Tel +34-91-7961300
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 2B BlackBio S.L.. (10/25/11). "Press Release: BlackBio Gets more than 2 Million Euros after Capital Increase and Public Funding".
Record changed: 2018-09-12


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for BlackBio (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top